AI
MRNA icon

AXS Investments’s Moderna MRNA Stock Holding History

AXS Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-740
Closed -$89.9K – 448
2023
Q2 		$89.9K Hold
740
– – 0.02% 309
2023
Q1 		$114K Buy
+740
New +$122K 0.04% 252
2021
Q3 		– Sell
-3,830
Closed -$900K – 176
2021
Q2 		$900K Sell
3,830
-1,300
-25% -$232K 0.27% 84
2021
Q1 		$672K Buy
+5,130
New +$743K 0.24% 89

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

AXS Investments's MRNA Position: Q3 2023 in Review

AXS Investments sold out of Moderna (MRNA) in Q3 2023, closing a stake of 740 shares — an estimated $89.9K sold.

AXS Investments first reported a position in MRNA in Q1 2021 and held it in 4 quarters. The position peaked at $900K in Q2 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • AXS Investments reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • AXS Investments sold 740 Moderna shares in Q3 2023, an estimated $89.9K.
  • AXS Investments first reported a position in Moderna in Q1 2021 and held it in 4 quarters.
  • AXS Investments's Moderna position peaked at $900K in Q2 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on AXS Investments's 13F filing for Q3 2023, filed 9 Nov 2023.